Search by Drug Name or NDC

    NDC 00008-1222-50 Pristiq 100 mg/1 Details

    Pristiq 100 mg/1

    Pristiq is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. The primary component is DESVENLAFAXINE SUCCINATE.

    Product Information

    NDC 00008-1222
    Product ID 0008-1222_2d58c489-3d71-4a13-8ef1-dc80788feec9
    Associated GPIs 58180020207540
    GCN Sequence Number 063737
    GCN Sequence Number Description desvenlafaxine succinate TAB ER 24H 100 MG ORAL
    HIC3 H7C
    HIC3 Description SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS)
    GCN 99452
    HICL Sequence Number 035420
    HICL Sequence Number Description DESVENLAFAXINE SUCCINATE
    Brand/Generic Brand
    Proprietary Name Pristiq
    Proprietary Name Suffix Extended-Release
    Non-Proprietary Name desvenlafaxine succinate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name DESVENLAFAXINE SUCCINATE
    Labeler Name Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
    Pharmaceutical Class Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021992
    Listing Certified Through 2024-12-31

    Package

    NDC 00008-1222-50 (00008122250)

    NDC Package Code 0008-1222-50
    Billing NDC 00008122250
    Package 100 BLISTER PACK in 1 CARTON (0008-1222-50) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2008-05-01
    NDC Exclude Flag N
    Pricing Information N/A